Literature DB >> 18337609

Chemical immunosuppression in islet transplantation--friend or foe?

Lucienne Chatenoud1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18337609     DOI： 10.1056/NEJMcibr0708067

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition.

Authors:  Ying Li; Anthony W Frei; Ethan Y Yang; Irayme Labrada-Miravet; Chuqiao Sun; Yanan Rong; Magdalena M Samojlik; Allison L Bayer; Cherie L Stabler
Journal:  Biomaterials       Date:  2020-06-15       Impact factor: 12.479

Review 2.  State of the art of clinical islet transplantation and novel protocols of immunosuppression.

Authors:  A M James Shapiro
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

Review 3.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 4.  Porcine Islet Xenografts: a Clinical Source of ß-Cell Grafts.

Authors:  Bassem F Salama; Gregory S Korbutt
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

5.  Insulin independence after conversion from tacrolimus to cyclosporine in islet transplantation.

Authors:  Bengt von Zur-Mühlen; Gunnar Tufveson; Olle Korsgren
Journal:  Transpl Int       Date:  2012-08-17       Impact factor: 3.782

6.  SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients.

Authors:  Else M Balke; Simke Demeester; DaHae Lee; Pieter Gillard; Robert Hilbrands; Ursule Van de Velde; Bart J Van der Auwera; Zhidong Ling; Bart O Roep; Daniël G Pipeleers; Bart Keymeulen; Frans K Gorus
Journal:  Diabetologia       Date:  2018-04-20       Impact factor: 10.122

Review 7.  Update on islet transplantation.

Authors:  Michael McCall; A M James Shapiro
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

8.  Hydrogen-bonded multilayers of tannic acid as mediators of T-cell immunity.

Authors:  Veronika Kozlovskaya; Bing Xue; Weiqi Lei; Lindsey E Padgett; Hubert M Tse; Eugenia Kharlampieva
Journal:  Adv Healthc Mater       Date:  2014-12-09       Impact factor: 9.933

9.  Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes.

Authors:  Anne Jörns; Muharrem Akin; Tanja Arndt; Taivankhuu Terbish; Andreas Meyer Zu Vilsendorf; Dirk Wedekind; Hans-Jürgen Hedrich; Sigurd Lenzen
Journal:  J Mol Med (Berl)       Date:  2014-03-07       Impact factor: 4.599

Review 10.  New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes.

Authors:  S Cernea; P Pozzilli
Journal:  Diabet Med       Date:  2008-11       Impact factor: 4.359
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.